These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 9849050

  • 1. [Regulation of T-cell activation by CD28 and CTLA-4].
    Nagel T, Kalden JR, Manger B.
    Med Klin (Munich); 1998 Oct 15; 93(10):592-7. PubMed ID: 9849050
    [Abstract] [Full Text] [Related]

  • 2. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F, Nierkens S, de Jong W, Wehrens EJ, Boon L, van Kooten P, Knippels LM, Pieters R.
    J Immunol; 2007 Jun 01; 178(11):6894-900. PubMed ID: 17513738
    [Abstract] [Full Text] [Related]

  • 3. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
    Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JG.
    J Exp Med; 2000 Sep 04; 192(5):681-94. PubMed ID: 10974034
    [Abstract] [Full Text] [Related]

  • 4. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
    Van Gool SW, Zhang Y, Kasran A, de Boer M, Ceuppens JL.
    Scand J Immunol; 1996 Jul 04; 44(1):21-9. PubMed ID: 8693288
    [Abstract] [Full Text] [Related]

  • 5. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K, Van Gool SW, Kasran A, Ceuppens JL, Boogaerts MA, Vandenberghe P.
    Immunology; 1999 Nov 04; 98(3):413-21. PubMed ID: 10583602
    [Abstract] [Full Text] [Related]

  • 6. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
    García-Cózar FJ, Molina IJ, Cuadrado MJ, Marubayashi M, Peña J, Santamaría M.
    Clin Exp Immunol; 1996 Apr 04; 104(1):72-9. PubMed ID: 8603537
    [Abstract] [Full Text] [Related]

  • 7. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A, Kishimoto K, Dong VM, Sho M, Salama AD, Anosova NG, Benichou G, Mandelbrot DA, Sharpe AH, Turka LA, Auchincloss H, Sayegh MH.
    J Immunol; 2001 Jul 01; 167(1):140-6. PubMed ID: 11418642
    [Abstract] [Full Text] [Related]

  • 8. Costimulation and its role in organ transplantation.
    Bluestone JA.
    Clin Transplant; 1996 Feb 01; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [Abstract] [Full Text] [Related]

  • 9. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
    Lazetic S, Leong SR, Chang JC, Ong R, Dawes G, Punnonen J.
    J Biol Chem; 2002 Oct 11; 277(41):38660-8. PubMed ID: 12167647
    [Abstract] [Full Text] [Related]

  • 10. Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody.
    Vanhove B, Laflamme G, Coulon F, Mougin M, Vusio P, Haspot F, Tiollier J, Soulillou JP.
    Blood; 2003 Jul 15; 102(2):564-70. PubMed ID: 12649149
    [Abstract] [Full Text] [Related]

  • 11. CD28 function: a balance of costimulatory and regulatory signals.
    Bour-Jordan H, Blueston JA.
    J Clin Immunol; 2002 Jan 15; 22(1):1-7. PubMed ID: 11958588
    [Abstract] [Full Text] [Related]

  • 12. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B, Nash MA, Lenzi R, Platsoucas CD, Freedman RS.
    Clin Exp Immunol; 2000 Jan 15; 119(1):19-27. PubMed ID: 10606960
    [Abstract] [Full Text] [Related]

  • 13. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation.
    Li D, Gál I, Vermes C, Alegre ML, Chong AS, Chen L, Shao Q, Adarichev V, Xu X, Koreny T, Mikecz K, Finnegan A, Glant TT, Zhang J.
    J Immunol; 2004 Dec 15; 173(12):7135-9. PubMed ID: 15585834
    [Abstract] [Full Text] [Related]

  • 14. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
    Krummel MF, Allison JP.
    J Exp Med; 1995 Aug 01; 182(2):459-65. PubMed ID: 7543139
    [Abstract] [Full Text] [Related]

  • 15. Effect of CD80 and CD86 on T cell cytokine production.
    Petro TM, Chen SS, Panther RB.
    Immunol Invest; 1995 Nov 01; 24(6):965-76. PubMed ID: 8575841
    [Abstract] [Full Text] [Related]

  • 16. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
    Daikh D, Wofsy D, Imboden JB.
    J Leukoc Biol; 1997 Aug 01; 62(2):156-62. PubMed ID: 9261329
    [Abstract] [Full Text] [Related]

  • 17. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS, Greene JL, Tan P, Bradshaw J, Ledbetter JA, Anasetti C, Damle NK.
    J Exp Med; 1992 Dec 01; 176(6):1595-604. PubMed ID: 1334116
    [Abstract] [Full Text] [Related]

  • 18. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.
    Rennert P, Furlong K, Jellis C, Greenfield E, Freeman GJ, Ueda Y, Levine B, June CH, Gray GS.
    Int Immunol; 1997 Jun 01; 9(6):805-13. PubMed ID: 9199963
    [Abstract] [Full Text] [Related]

  • 19. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK, Klussman K, Leytze G, Myrdal S, Aruffo A, Ledbetter JA, Linsley PS.
    J Immunol; 1994 Mar 15; 152(6):2686-97. PubMed ID: 7511623
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.